Expanded Access Program of Dupilumab in Adults With Severe Immunoglobulin E (IgE)-Mediated Food A… (NCT06631677) | Clinical Trial Compass
NO_LONGER_AVAILABLENot Applicable
Expanded Access Program of Dupilumab in Adults With Severe Immunoglobulin E (IgE)-Mediated Food Allergy Who Have Been Previously Treated With Linvoseltamab and Background Dupilumab in the Parent Study R5458-668-ALG-2219 (NCT06369467)
Plain-language summary
This is an expanded access program of dupilumab that was never initiated and, therefore, not available.